{"id":50489,"date":"2022-11-04T08:02:12","date_gmt":"2022-11-04T07:02:12","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/beckley-psytech-to-attend-and-present-at-the-jefferies-london-healthcare-conference-november-15-17-2022\/"},"modified":"2022-11-04T08:02:12","modified_gmt":"2022-11-04T07:02:12","slug":"beckley-psytech-to-attend-and-present-at-the-jefferies-london-healthcare-conference-november-15-17-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/beckley-psytech-to-attend-and-present-at-the-jefferies-london-healthcare-conference-november-15-17-2022\/","title":{"rendered":"Beckley Psytech to Attend and Present at the Jefferies London Healthcare Conference \u2013 November 15-17, 2022"},"content":{"rendered":"<div>\n<p>OXFORD, England&#8211;(BUSINESS WIRE)&#8211;Beckley Psytech Limited, a private, clinical-stage biotechnology company dedicated to addressing neuropsychiatric conditions through the novel application of psychedelic medicines, today announces that Cosmo Feilding Mellen, Chief Executive Officer, Steve Wooding, Chief Scientific Officer and Michael Norris, Chief Financial Officer, will attend the Jefferies London Healthcare Conference, being held in London from 15<sup>th<\/sup> to 17<sup>th<\/sup> November 2022, and will hold a formal company presentation.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221104005095\/en\/1625230\/4\/Beckley_Psytech_Logo_high_res.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221104005095\/en\/1625230\/21\/Beckley_Psytech_Logo_high_res.jpg\"><\/a><\/p>\n<p>\nThe presentation is scheduled to take place on Thursday, 17<sup>th<\/sup> November 2022, at 11.30 am GMT.\n<\/p>\n<p>\nTo request a one-on-one meeting with the Beckley Psytech team, please contact <a target=\"_blank\" href=\"&#x6d;&#97;&#105;l&#x74;&#x6f;&#58;g&#x76;&#x61;&#110;r&#x65;&#x6e;&#116;e&#x72;&#x67;&#104;e&#x6d;&#x40;&#108;i&#x66;&#x65;&#115;&#99;i&#x61;&#x64;&#118;i&#x73;&#x6f;&#114;s&#x2e;&#x63;&#111;m\" rel=\"nofollow noopener\" shape=\"rect\">g&#118;&#x61;&#x6e;&#x72;e&#110;&#116;&#x65;&#x72;g&#104;&#101;&#x6d;&#x40;li&#102;&#x65;&#x73;&#x63;i&#97;&#x64;&#x76;&#x69;s&#111;&#114;&#x73;&#x2e;c&#111;&#109;<\/a>.\n<\/p>\n<p class=\"bwalignc\">\n<b>-Ends-<\/b>\n<\/p>\n<p>\n<b>Beckley Psytech<\/b> &#8211; <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.beckleypsytech.com&amp;esheet=52960530&amp;newsitemid=20221104005095&amp;lan=en-US&amp;anchor=www.beckleypsytech.com&amp;index=1&amp;md5=164b00c445344153fc8e844c266c4d51\" rel=\"nofollow noopener\" shape=\"rect\">www.beckleypsytech.com<\/a>\n<\/p>\n<p>\nBeckley Psytech is a private, clinical stage biotechnology company dedicated to improving the lives of people suffering from neuropsychiatric disorders by developing a pipeline of psychedelic compounds into licensed pharmaceutical medicines. Our vision is for clinically validated psychedelic medicines to be integrated into modern medical practice in order to help patients living with depression and other profoundly debilitating neuropsychiatric conditions with a high unmet need. Founded in 2019, and underpinned by more than two decades of pioneering scientific research from the Beckley Foundation, we combine world-leading psychedelic science with deep neuropsychiatric drug development expertise in order to optimise patient outcomes, improve treatment and ease the burden these conditions have on individuals and society.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Beckley Psytech<\/b><br \/>Cosmo Feilding Mellen<br \/>\n<br \/>Chief Executive Officer<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;i&#x6c;t&#111;&#x3a;&#105;&#x6e;f&#111;&#x40;&#98;&#x65;c&#x6b;&#x6c;&#101;&#x79;p&#x73;y&#116;&#x65;&#99;&#x68;&#46;&#99;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x69;&#x6e;&#x66;&#x6f;&#x40;&#x62;&#x65;&#x63;&#x6b;&#x6c;&#x65;&#121;&#112;&#115;&#121;&#116;&#101;&#99;h&#46;com<\/a><\/p>\n<p><b>Communications<\/b><br \/>FTI Consulting<br \/>\n<br \/>Ben Atwell \/ Mike Trace<br \/>\n<br \/>+44 (0)20 3727 1000<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#x74;&#x6f;&#58;&#98;&#101;&#99;kley&#x70;&#x73;&#x79;&#x74;&#x65;&#x63;&#104;&#64;&#102;&#116;&#105;con&#x73;&#x75;&#x6c;&#x74;&#x69;&#x6e;&#103;&#46;&#99;&#111;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#98;&#x65;&#x63;k&#108;&#x65;y&#112;&#x73;y&#116;&#x65;c&#104;&#x40;&#x66;&#116;&#x69;&#x63;o&#110;&#x73;u&#108;&#x74;i&#110;&#x67;&#x2e;&#99;&#x6f;&#x6d;<\/a><\/p>\n<p><b>Investor Relations<\/b><br \/>LifeSci Advisors<br \/>\n<br \/>Guillaume van Renterghem<br \/>\n<br \/>+41 76 735 01 31<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;i&#x6c;&#116;o&#x3a;&#x67;&#118;&#x61;&#x6e;&#114;e&#x6e;&#116;e&#x72;&#x67;&#104;&#x65;&#x6d;&#64;l&#x69;&#102;e&#x73;&#x63;&#105;&#x61;&#x64;&#118;i&#x73;&#111;r&#x73;&#x2e;&#99;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x67;&#x76;&#x61;&#x6e;&#x72;&#x65;&#x6e;&#x74;&#x65;&#x72;&#x67;&#104;&#101;&#109;&#64;&#108;&#105;&#102;esciad&#x76;&#x69;&#x73;&#x6f;&#x72;&#x73;&#x2e;&#x63;&#x6f;&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>OXFORD, England&#8211;(BUSINESS WIRE)&#8211;Beckley Psytech Limited, a private, clinical-stage biotechnology company dedicated to addressing neuropsychiatric conditions through the novel application of psychedelic medicines, today announces that Cosmo Feilding Mellen, Chief Executive Officer, Steve Wooding, Chief Scientific Officer and Michael Norris, Chief Financial Officer, will attend the Jefferies London Healthcare Conference, being held in London from 15th &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/beckley-psytech-to-attend-and-present-at-the-jefferies-london-healthcare-conference-november-15-17-2022\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50489","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Beckley Psytech to Attend and Present at the Jefferies London Healthcare Conference \u2013 November 15-17, 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/beckley-psytech-to-attend-and-present-at-the-jefferies-london-healthcare-conference-november-15-17-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Beckley Psytech to Attend and Present at the Jefferies London Healthcare Conference \u2013 November 15-17, 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"OXFORD, England&#8211;(BUSINESS WIRE)&#8211;Beckley Psytech Limited, a private, clinical-stage biotechnology company dedicated to addressing neuropsychiatric conditions through the novel application of psychedelic medicines, today announces that Cosmo Feilding Mellen, Chief Executive Officer, Steve Wooding, Chief Scientific Officer and Michael Norris, Chief Financial Officer, will attend the Jefferies London Healthcare Conference, being held in London from 15th ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/beckley-psytech-to-attend-and-present-at-the-jefferies-london-healthcare-conference-november-15-17-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-04T07:02:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221104005095\/en\/1625230\/21\/Beckley_Psytech_Logo_high_res.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/beckley-psytech-to-attend-and-present-at-the-jefferies-london-healthcare-conference-november-15-17-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/beckley-psytech-to-attend-and-present-at-the-jefferies-london-healthcare-conference-november-15-17-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Beckley Psytech to Attend and Present at the Jefferies London Healthcare Conference \u2013 November 15-17, 2022\",\"datePublished\":\"2022-11-04T07:02:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/beckley-psytech-to-attend-and-present-at-the-jefferies-london-healthcare-conference-november-15-17-2022\\\/\"},\"wordCount\":261,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/beckley-psytech-to-attend-and-present-at-the-jefferies-london-healthcare-conference-november-15-17-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221104005095\\\/en\\\/1625230\\\/21\\\/Beckley_Psytech_Logo_high_res.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/beckley-psytech-to-attend-and-present-at-the-jefferies-london-healthcare-conference-november-15-17-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/beckley-psytech-to-attend-and-present-at-the-jefferies-london-healthcare-conference-november-15-17-2022\\\/\",\"name\":\"Beckley Psytech to Attend and Present at the Jefferies London Healthcare Conference \u2013 November 15-17, 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/beckley-psytech-to-attend-and-present-at-the-jefferies-london-healthcare-conference-november-15-17-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/beckley-psytech-to-attend-and-present-at-the-jefferies-london-healthcare-conference-november-15-17-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221104005095\\\/en\\\/1625230\\\/21\\\/Beckley_Psytech_Logo_high_res.jpg\",\"datePublished\":\"2022-11-04T07:02:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/beckley-psytech-to-attend-and-present-at-the-jefferies-london-healthcare-conference-november-15-17-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/beckley-psytech-to-attend-and-present-at-the-jefferies-london-healthcare-conference-november-15-17-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/beckley-psytech-to-attend-and-present-at-the-jefferies-london-healthcare-conference-november-15-17-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221104005095\\\/en\\\/1625230\\\/21\\\/Beckley_Psytech_Logo_high_res.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221104005095\\\/en\\\/1625230\\\/21\\\/Beckley_Psytech_Logo_high_res.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/beckley-psytech-to-attend-and-present-at-the-jefferies-london-healthcare-conference-november-15-17-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Beckley Psytech to Attend and Present at the Jefferies London Healthcare Conference \u2013 November 15-17, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Beckley Psytech to Attend and Present at the Jefferies London Healthcare Conference \u2013 November 15-17, 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/beckley-psytech-to-attend-and-present-at-the-jefferies-london-healthcare-conference-november-15-17-2022\/","og_locale":"en_US","og_type":"article","og_title":"Beckley Psytech to Attend and Present at the Jefferies London Healthcare Conference \u2013 November 15-17, 2022 - Pharma Trend","og_description":"OXFORD, England&#8211;(BUSINESS WIRE)&#8211;Beckley Psytech Limited, a private, clinical-stage biotechnology company dedicated to addressing neuropsychiatric conditions through the novel application of psychedelic medicines, today announces that Cosmo Feilding Mellen, Chief Executive Officer, Steve Wooding, Chief Scientific Officer and Michael Norris, Chief Financial Officer, will attend the Jefferies London Healthcare Conference, being held in London from 15th ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/beckley-psytech-to-attend-and-present-at-the-jefferies-london-healthcare-conference-november-15-17-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-04T07:02:12+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221104005095\/en\/1625230\/21\/Beckley_Psytech_Logo_high_res.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/beckley-psytech-to-attend-and-present-at-the-jefferies-london-healthcare-conference-november-15-17-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/beckley-psytech-to-attend-and-present-at-the-jefferies-london-healthcare-conference-november-15-17-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Beckley Psytech to Attend and Present at the Jefferies London Healthcare Conference \u2013 November 15-17, 2022","datePublished":"2022-11-04T07:02:12+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/beckley-psytech-to-attend-and-present-at-the-jefferies-london-healthcare-conference-november-15-17-2022\/"},"wordCount":261,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/beckley-psytech-to-attend-and-present-at-the-jefferies-london-healthcare-conference-november-15-17-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221104005095\/en\/1625230\/21\/Beckley_Psytech_Logo_high_res.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/beckley-psytech-to-attend-and-present-at-the-jefferies-london-healthcare-conference-november-15-17-2022\/","url":"https:\/\/pharma-trend.com\/en\/beckley-psytech-to-attend-and-present-at-the-jefferies-london-healthcare-conference-november-15-17-2022\/","name":"Beckley Psytech to Attend and Present at the Jefferies London Healthcare Conference \u2013 November 15-17, 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/beckley-psytech-to-attend-and-present-at-the-jefferies-london-healthcare-conference-november-15-17-2022\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/beckley-psytech-to-attend-and-present-at-the-jefferies-london-healthcare-conference-november-15-17-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221104005095\/en\/1625230\/21\/Beckley_Psytech_Logo_high_res.jpg","datePublished":"2022-11-04T07:02:12+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/beckley-psytech-to-attend-and-present-at-the-jefferies-london-healthcare-conference-november-15-17-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/beckley-psytech-to-attend-and-present-at-the-jefferies-london-healthcare-conference-november-15-17-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/beckley-psytech-to-attend-and-present-at-the-jefferies-london-healthcare-conference-november-15-17-2022\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221104005095\/en\/1625230\/21\/Beckley_Psytech_Logo_high_res.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221104005095\/en\/1625230\/21\/Beckley_Psytech_Logo_high_res.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/beckley-psytech-to-attend-and-present-at-the-jefferies-london-healthcare-conference-november-15-17-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Beckley Psytech to Attend and Present at the Jefferies London Healthcare Conference \u2013 November 15-17, 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50489","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50489"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50489\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50489"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50489"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50489"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}